SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Alkem Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
539523 INE540L01014 1142.874838 ALKEM 0.79 67,969.12 30.4 187.01 2
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales2542.032372.172044.94
Other Operating Income0.000.000.00
Other Income 164.44164.77162.65
Total Income2706.472536.942207.59
Total Expenditure 1771.351751.691748.15
PBIDT935.12785.25459.44
Interest 12.7512.7916.91
PBDT922.37772.46442.53
Depreciation58.5958.8991.64
Tax123.56109.3436.75
Fringe Benefit Tax0.000.000.00
Deferred Tax-46.51-51.9337.20
Reported Profit After Tax786.73656.16276.94
Extra-ordinary Items 63.0745.8951.06
Adjusted Profit After Extra-ordinary item723.66610.27225.88
    
EPS (Unit Curr.)65.8054.8823.17
EPS (Adj) (Unit Curr.)65.8054.8823.17
Calculated EPS (Unit Curr.)65.8154.8923.17
Calculated EPS (Adj) (Unit Curr.)65.8154.8923.17
Calculated EPS (Ann.) (Unit Curr.)263.23219.5492.66
Calculated EPS (Adj) (Ann.) (Unit Curr.)263.23219.5492.66
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity23.9123.9123.91
Reserve & Surplus13640.870.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)36.7933.1022.47
PBDTM(%)36.2832.5621.64
PATM(%)30.9527.6613.54